Skip to content

i-Scan for the Detection of Helicobacter Pylori

i-Scan for the Detection of Helicobacter Pylori

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02385045
Enrollment
157
Registered
2015-03-11
Start date
2014-10-31
Completion date
2016-10-31
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastritis

Brief summary

This study aims to assess whether iScan, an intra-endoscopic imaging technique is an accurate and reliable tool in detecting and characterising Helicobacter pylori (H pylori) and comparing this to standard endoscopic imaging with white light endoscopy (WLE), narrow band imaging (NBI) and histology.

Detailed description

The ultimate goal of endoscopy will be the 'optical biopsy' i.e. forgoing the need to take histological samples to make a diagnosis in order to reduce complication rates, cost and time. There are a number of imaging techniques which promise to improve our diagnostic rates for pathology, but there have been few comparative studies. This is randomized controlled parallel trial in a 1:1 ratio with examination of the upper gastrointestinal tract with WLE followed by either NBI or iscan. (Note: Prior to commencement of the study, technical issues and operational changes in our organisation forced the removal of the Pentax 'i-scan' endoscopes. Recruitment to this arm was anticipated, but was ultimately not possible.) Patients attending the department for routine examinations for dyspepsia and abdominal pain will be randomised into 2 study arms (1WLE and NBI, and the other - WLE and iscan). The investigator carrying out the procedure will be blinded to the indication for the procedure until a full examination with both white light endoscopy and either NBI or iscan has been used as this could lead to bias. They will determine if H pylori is present, and if so the severity of infection with WLE and again with either NBI or iscan depending on their study arm. Histopathological confirmation of H pylori and an assessment to the degree of infection will be assessed with samples taken using the updated Sydney system (5 gastric samples from different parts of the stomach). The endoscopists reviewing the images will be blinded to all patient information and indications throughout the study period. Questionnaires will then be given to the endoscopists to determine what endoscopic features led them to their diagnosis.

Interventions

DEVICEi-scan

i-scan function is located on the head of the Pentax endoscopes

narrow band imaging function is located on the head of Olympus endoscopes

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• All patients attending for a routine diagnostic endoscopic procedure at St Mary's Hospital NHS Trust for dyspepsia and abdominal pain

Exclusion criteria

* Patients attending for a therapeutic endoscopic procedure e.g. variceal banding, stent insertion, balloon dilatation. * Patients with a known diagnosis e.g. upper gastrointestinal cancer * Patients previously treated with HP eradication therapy * Patients who had taken PPI, H2 receptor antagonists and antibiotics within 4 weeks * Patients with acute gastrointestinal bleeding * Patients who'd had previous gastric surgery * Patients with chronic liver disease * Patients with abnormal coagulation or any other contra-indication to use of standard biopsy in routine diagnostic endoscopic procedures * Patients who are unable or unwilling to give informed consent * Patients under the age of 18 years

Design outcomes

Primary

MeasureTime frameDescription
Successful Diagnosis of Helicobacter Pylori Using Imaging Modality1 yearThe endoscopic assessment of the presence of H pylori using standard endoscopy plus NBI will be compared to histological assessment. Inter-observer variability of assessment of the presence of H pylori will be compared between endoscopic imaging techniques

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Narrow Band Imaging
Narrow band imaging function (Olympus endoscopes) narrow band imaging: narrow band imaging function is located on the head of Olympus endoscopes
153
Total153

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyEndoscopy could not be completed4

Baseline characteristics

CharacteristicNarrow Band Imaging
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
47 Participants
Age, Categorical
Between 18 and 65 years
106 Participants
Age, Continuous54.2 years
STANDARD_DEVIATION 16.8
Region of Enrollment
United Kingdom
153 Participants
Sex: Female, Male
Female
87 Participants
Sex: Female, Male
Male
66 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 153
other
Total, other adverse events
0 / 153
serious
Total, serious adverse events
0 / 153

Outcome results

Primary

Successful Diagnosis of Helicobacter Pylori Using Imaging Modality

The endoscopic assessment of the presence of H pylori using standard endoscopy plus NBI will be compared to histological assessment. Inter-observer variability of assessment of the presence of H pylori will be compared between endoscopic imaging techniques

Time frame: 1 year

Population: All patients presenting for endoscopy who were recruited to the study.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Narrow Band ImagingSuccessful Diagnosis of Helicobacter Pylori Using Imaging ModalityH Pylori Positive28 Participants
Narrow Band ImagingSuccessful Diagnosis of Helicobacter Pylori Using Imaging ModalityH Pylori Negative125 Participants

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026